share_log

UBS Maintains Buy on CareMax, Lowers Price Target to $6

UBS Maintains Buy on CareMax, Lowers Price Target to $6

瑞银维持在CareMax上买入,将目标价下调至6美元
Benzinga Real-time News ·  2023/01/06 08:43

UBS analyst Andrew Mok maintains CareMax (NASDAQ:CMAX) with a Buy and lowers the price target from $10 to $6.

瑞银分析师Andrew Mok维持纳斯达克(Kleiner Perkins Caufield&Byers)的买入评级,并将目标价从10美元下调至6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发